"This was recently demonstrated by a packaging launch involving GlaxoSmithKline’s anti-viral product Relenza®, which has been recommended by a number of global health authorities for treatment of H1N1 influenza. The Corby team moved from preliminary discussion through design, implementation, validation, and into full production in just twelve weeks, helping GlaxoSmithKline meet increasing demand for the product.
"
http://www.businesswire.com/portal/site/google/?ndmViewId=news_view&newsId=20091006005374&newsLang=en
- Forums
- ASX - By Stock
- BTA
- good to see increased relenza production
good to see increased relenza production
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)